Abstract: Federal and state lawmakers have recently been taking steps to authorize limited access to psychedelics, given the abundant and growing research on their potential in tackling major mental health conditions like post-traumatic stress disorder (PTSD), addiction, treatment-resistant depression, and more. The incoming Trump administration has promised sweeping reforms to federal health agencies, and Robert F. Kennedy, Jr. - nominated to lead the Department of Health and Human Services (HHS) - has indicated that reversing the federal suppression of psychedelics is a priority. Several executive orders could help make psychedelic therapies available to veterans, first responders, trauma survivors, and other Americans who may benefit.